"Diabetic Retinopathy" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Disease of the RETINA as a complication of DIABETES MELLITUS. It is characterized by the progressive microvascular complications, such as ANEURYSM, interretinal EDEMA, and intraocular PATHOLOGIC NEOVASCULARIZATION.
Descriptor ID |
D003930
|
MeSH Number(s) |
C11.768.257 C14.907.320.382 C19.246.099.500.382
|
Concept/Terms |
Diabetic Retinopathy- Diabetic Retinopathy
- Diabetic Retinopathies
- Retinopathies, Diabetic
- Retinopathy, Diabetic
|
Below are MeSH descriptors whose meaning is more general than "Diabetic Retinopathy".
Below are MeSH descriptors whose meaning is more specific than "Diabetic Retinopathy".
This graph shows the total number of publications written about "Diabetic Retinopathy" by people in this website by year, and whether "Diabetic Retinopathy" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 1 | 0 | 1 |
1998 | 0 | 1 | 1 |
2001 | 1 | 0 | 1 |
2002 | 1 | 1 | 2 |
2003 | 1 | 1 | 2 |
2004 | 1 | 0 | 1 |
2006 | 1 | 2 | 3 |
2007 | 1 | 0 | 1 |
2008 | 1 | 0 | 1 |
2009 | 1 | 0 | 1 |
2010 | 4 | 0 | 4 |
2011 | 2 | 0 | 2 |
2012 | 1 | 0 | 1 |
2013 | 2 | 0 | 2 |
2014 | 2 | 0 | 2 |
2015 | 3 | 0 | 3 |
2016 | 9 | 1 | 10 |
2017 | 11 | 1 | 12 |
2018 | 8 | 0 | 8 |
2019 | 18 | 0 | 18 |
2020 | 18 | 1 | 19 |
2021 | 19 | 0 | 19 |
2022 | 19 | 0 | 19 |
2023 | 17 | 0 | 17 |
2024 | 3 | 0 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Diabetic Retinopathy" by people in Profiles.
-
Intravitreal aflibercept 8 mg in diabetic macular oedema (PHOTON): 48-week results from a randomised, double-masked, non-inferiority, phase 2/3 trial. Lancet. 2024 Mar 23; 403(10432):1153-1163.
-
Use of Diabetes Technologies and Retinopathy in Adults With Type 1 Diabetes. JAMA Netw Open. 2024 Mar 04; 7(3):e240728.
-
Autonomous artificial intelligence increases screening and follow-up for diabetic retinopathy in youth: the ACCESS randomized control trial. Nat Commun. 2024 Jan 11; 15(1):421.
-
Management of Nonproliferative Diabetic Retinopathy: Where Do We Stand? Int Ophthalmol Clin. 2024 Jan 01; 64(1):83-96.
-
Treatment Options for Diabetic Macular Edema. Int Ophthalmol Clin. 2024 Jan 01; 64(1):57-69.
-
Treatment of Proliferative Diabetic Retinopathy in 2023. Int Ophthalmol Clin. 2024 Jan 01; 64(1):71-82.
-
Factors Influencing Eye Screening Adherence Among Latinx Patients With Diabetes: A Qualitative Study. Transl Vis Sci Technol. 2023 12 01; 12(12):8.
-
Efficacy and Safety of Brolucizumab for Diabetic Macular Edema: The KINGFISHER Randomized Clinical Trial. JAMA Ophthalmol. 2023 Dec 01; 141(12):1152-1160.
-
Risk Factors for Nondiagnostic Imaging in a Real-World Deployment of Artificial Intelligence Diabetic Retinal Examinations in an Integrated Healthcare System: Maximizing Workflow Efficiency Through Predictive Dilation. J Diabetes Sci Technol. 2024 Mar; 18(2):302-308.
-
Subthreshold Compared with Threshold Macular Photocoagulation for Diabetic Macular Edema: A Systematic Review and Meta-Analysis. Ophthalmol Retina. 2024 Mar; 8(3):223-233.